Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
Diseases of the Colon and Rectum|August 30, 2007
High frequency of chromosome 14 deletion in early-onset colon cancerNajat Mourra, Guy Zeitoun, Bruno Buecher, et al.
Cancers|July 27, 2022
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 ExpressionLaurys Boudin, Alexandre De Nonneville, Pascal Finetti, et al.
Cell Communication and Signaling : CCS|January 3, 2024
Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancerZainab Hussain, Thomas Bertran, Pascal Finetti, et al.
Cancer Genomics & Proteomics|July 9, 2011
Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancerRenaud Sabatier, Pascal Finetti, Nathalie Cervera, et al.
Breast Cancer Research : BCR|January 7, 2009
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesGwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, et al.
Plos One|November 24, 2011
Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancerRenaud Sabatier, Pascal Finetti, José Adelaide, et al.
Cancers|August 16, 2019
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast CancersAlexandre de Nonneville, Pascal Finetti, José Adelaide, et al.
Oncotarget|May 6, 2015
PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapyFrançois Bertucci, Pascal Finetti, Cécile Colpaert, et al.
BMC Research Notes|June 8, 2013
Djeen (Database for Joomla!'s Extensible Engine): a research information management system for flexible multi-technology project administrationOlivier Stahl, Hugo Duvergey, Arnaud Guille, et al.
In Vivo (Athens, Greece)|December 29, 2019
Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian CancerMaroua Manai, Raoudha Doghri, Pascal Finetti, et al.
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Diseases of the Colon and Rectum|August 30, 2007
High frequency of chromosome 14 deletion in early-onset colon cancerNajat Mourra, Guy Zeitoun, Bruno Buecher, et al.
Cancers|July 27, 2022
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 ExpressionLaurys Boudin, Alexandre De Nonneville, Pascal Finetti, et al.
Cell Communication and Signaling : CCS|January 3, 2024
Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancerZainab Hussain, Thomas Bertran, Pascal Finetti, et al.
Cancer Genomics & Proteomics|July 9, 2011
Gene expression profiling and its utility in prediction of local relapse after breast-conserving therapy in early breast cancerRenaud Sabatier, Pascal Finetti, Nathalie Cervera, et al.
Breast Cancer Research : BCR|January 7, 2009
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesGwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, et al.
Plos One|November 24, 2011
Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancerRenaud Sabatier, Pascal Finetti, José Adelaide, et al.
Cancers|August 16, 2019
A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast CancersAlexandre de Nonneville, Pascal Finetti, José Adelaide, et al.
Oncotarget|May 6, 2015
PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapyFrançois Bertucci, Pascal Finetti, Cécile Colpaert, et al.
BMC Research Notes|June 8, 2013
Djeen (Database for Joomla!'s Extensible Engine): a research information management system for flexible multi-technology project administrationOlivier Stahl, Hugo Duvergey, Arnaud Guille, et al.
In Vivo (Athens, Greece)|December 29, 2019
Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian CancerMaroua Manai, Raoudha Doghri, Pascal Finetti, et al.
Pageof 18